These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21177669)

  • 61. Identification of NDM-1-producing Enterobacteriaceae in Norway.
    Samuelsen Ø; Thilesen CM; Heggelund L; Vada AN; Kümmel A; Sundsfjord A
    J Antimicrob Chemother; 2011 Mar; 66(3):670-2. PubMed ID: 21172785
    [No Abstract]   [Full Text] [Related]  

  • 62. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression.
    Corvec S; Lepelletier D; Reynaud A; Dauvergne S; Giraudeau C; Caroff N
    Int J Antimicrob Agents; 2008 Aug; 32(2):196-8. PubMed ID: 18571906
    [No Abstract]   [Full Text] [Related]  

  • 63. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
    Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
    J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli.
    Sorlózano A; Gutiérrez J; Romero JM; de Dios Luna J; Damas M; Piédrola G
    J Basic Microbiol; 2007 Oct; 47(5):413-6. PubMed ID: 17910106
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enigmatic occurrence of NDM-7 enzyme in the community.
    van der Mee-Marquet N; Diene SM; Chopin F; Goudeau A; François P
    Int J Antimicrob Agents; 2016 Jun; 47(6):505-7. PubMed ID: 27178253
    [No Abstract]   [Full Text] [Related]  

  • 66. First description of plasmid-mediated colistin-resistant extended-spectrum β-lactamase-producing Escherichia coli in a wild migratory bird from Asia.
    Mohsin M; Raza S; Roschanski N; Schaufler K; Guenther S
    Int J Antimicrob Agents; 2016 Oct; 48(4):463-4. PubMed ID: 27451084
    [No Abstract]   [Full Text] [Related]  

  • 67. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.
    Odeh R; Kelkar S; Hujer AM; Bonomo RA; Schreckenberger PC; Quinn JP
    Clin Infect Dis; 2002 Jul; 35(2):140-5. PubMed ID: 12087519
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Susceptibility pattern of extended-spectrum beta-lactamase producing bacteria isolated from inpatients to five antimicrobial drugs in a community hospital in Northern Israel.
    Colodner R; Raz R; Chazan B; Sakran W
    Int J Antimicrob Agents; 2004 Oct; 24(4):409-10. PubMed ID: 15380271
    [No Abstract]   [Full Text] [Related]  

  • 69. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Tan TY; Ng SY; Teo L; Koh Y; Teok CH
    J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
    Papagiannitsis CC; Loli A; Tzouvelekis LS; Tzelepi E; Arlet G; Miriagou V
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2185-8. PubMed ID: 17353248
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MLST typing of Escherichia coli isolates overproducing AmpC {beta}-lactamase.
    Guillouzouic A; Caroff N; Dauvergne S; Lepelletier D; Perrin Guyomard A; Kempf I; Reynaud A; Corvec S
    J Antimicrob Chemother; 2009 Jun; 63(6):1290-2. PubMed ID: 19307170
    [No Abstract]   [Full Text] [Related]  

  • 72. Escherichia coli from Italy producing OXA-48 carbapenemase encoded by a novel Tn1999 transposon derivative.
    Giani T; Conte V; Di Pilato V; Aschbacher R; Weber C; Larcher C; Rossolini GM
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2211-3. PubMed ID: 22290939
    [No Abstract]   [Full Text] [Related]  

  • 73. Emergence of plasmid-mediated colistin resistance and New Delhi metallo-β-lactamase genes in extensively drug-resistant Escherichia coli isolated from a patient in Thailand.
    Paveenkittiporn W; Kerdsin A; Chokngam S; Bunthi C; Sangkitporn S; Gregory CJ
    Diagn Microbiol Infect Dis; 2017 Feb; 87(2):157-159. PubMed ID: 27894674
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinity.
    Landman D; Urban C; Bäcker M; Kelly P; Shah N; Babu E; Bratu S; Quale J
    J Clin Microbiol; 2010 Dec; 48(12):4604-7. PubMed ID: 20926706
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ongoing dissemination of OXA-244 carbapenemase-producing Escherichia coli in Switzerland and their detection.
    Masseron A; Poirel L; Falgenhauer L; Imirzalioglu C; Kessler J; Chakraborty T; Nordmann P
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115059. PubMed ID: 32387849
    [TBL] [Abstract][Full Text] [Related]  

  • 76. armA and aminoglycoside resistance in Escherichia coli.
    González-Zorn B; Teshager T; Casas M; Porrero MC; Moreno MA; Courvalin P; Domínguez L
    Emerg Infect Dis; 2005 Jun; 11(6):954-6. PubMed ID: 15963296
    [TBL] [Abstract][Full Text] [Related]  

  • 77. First report of an Escherichia coli from Lebanon carrying an OXA-181 carbapenemase resistance determinant.
    Bitar I; Dagher C; Salloum T; Araj G; Tokajian S
    J Glob Antimicrob Resist; 2018 Mar; 12():113-114. PubMed ID: 29353076
    [No Abstract]   [Full Text] [Related]  

  • 78. IncI1/ST3 plasmids contribute to the dissemination of the blaCTX-M-1 gene in Escherichia coli from several animal species in France.
    Dahmen S; Haenni M; Madec JY
    J Antimicrob Chemother; 2012 Dec; 67(12):3011-2. PubMed ID: 22872449
    [No Abstract]   [Full Text] [Related]  

  • 79. First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.
    Ikonomidis A; Labrou M; Afkou Z; Maniatis AN; Sofianou D; Tsakris A; Pournaras S
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3038-9. PubMed ID: 17517838
    [No Abstract]   [Full Text] [Related]  

  • 80. High frequency of IMP-6 among clinical isolates of metallo-β-lactamase-producing Escherichia coli in Japan.
    Yano H; Ogawa M; Endo S; Kakuta R; Kanamori H; Inomata S; Ishibashi N; Aoyagi T; Hatta M; Gu Y; Yamada M; Tokuda K; Kunishima H; Kitagawa M; Hirakata Y; Kaku M
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4554-5. PubMed ID: 22664972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.